Priming with the major RSV surface glycoprotein G expressed in a vaccinia virus vector (recombinant vaccinia virus [rVV]-G) fails to stimulate IFN-γ production by infiltrating cells during pulmonary challenge, leading to Th2 cytokine production and to lung eosinophilia. The gene discussed is IFNG; the disease is Increased total eosinophil count.